Pfizer  logo

Pfizer PFE

$ 27.06 1.75%

Annual report 2025
added 02-26-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

5.68 B

Market Cap[1]

$ 154 B

EBITDA (LTM)

$ 6.66 B

P/E (LTM)

10.91

P/S (LTM)

2.41

EPS (LTM)

2.44

Pfizer is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer's mission is to discover, develop, and deliver innovative medicines and vaccines that improve the lives of people around the world.

Pfizer has a diverse portfolio of products that address a range of health conditions, including cardiovascular disease, oncology, inflammation, immunology, and rare diseases. Some of the company's most well-known products include Lipitor, Viagra, and Lyrica.

In addition to developing new treatments, Pfizer is committed to improving access to healthcare for people in need. The company has established partnerships with governments, non-governmental organizations, and healthcare providers to expand access to its medicines and vaccines.

Pfizer is also dedicated to sustainability and reducing its environmental impact. The company has set ambitious goals to reduce greenhouse gas emissions, water consumption, and waste generation across its operations.

As a leading pharmaceutical company, Pfizer is constantly innovating and adapting to meet the changing needs of patients and healthcare providers. With a focus on research and development, access to healthcare, and sustainability, Pfizer is poised to continue making a positive impact on global health for years to come.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
AbCellera Biologics AbCellera Biologics
ABCL
$ 3.44 -4.32 % $ 1.03 B Nasdaq Global Select Market canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.79 -1.15 % $ 4.31 M Nasdaq Global Select Market chinaChina
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
ADMA Biologics ADMA Biologics
ADMA
$ 15.36 -2.17 % $ 3.66 B Nasdaq Global Market usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
$ 20.28 0.65 % $ 2.56 B Nasdaq Global Select Market,SPB usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.51 1.35 % $ 385 M Nasdaq Global Select Market britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Anika Therapeutics Anika Therapeutics
ANIK
$ 14.05 -1.44 % $ 206 M Nasdaq Global Select Market,SPB usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
$ 74.36 -1.64 % $ 1.44 B Nasdaq Global Market,SPB usaUSA
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
- - $ 521 M Nasdaq Capital Market usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
$ 162.43 0.6 % $ 8.08 B Nasdaq Global Market,SPB usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
$ 8.49 -0.18 % $ 1.75 B Nasdaq Global Select Market usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
$ 65.66 -0.78 % $ 12.6 B Nasdaq Global Select Market,SPB usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Berkeley Lights Berkeley Lights
BLI
- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 2.69 -0.74 % $ 908 M Nasdaq Capital Market israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
$ 61.3 1.21 % $ 11.8 B Nasdaq Global Select Market,SPB usaUSA
Burford Capital Limited Burford Capital Limited
BUR
$ 7.79 -5.75 % $ 1.28 B NYSE britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
Codexis Codexis
CDXS
$ 1.23 -2.38 % $ 90.3 M Nasdaq Global Select Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 3.18 -0.16 % $ 3.71 M Nasdaq Global Select Market usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.